Younes, Anas
AstraZeneca,
United Kingdom
2025 Rank: 28237
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 556 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28237 | 31058 |
| Total Cites | 1722 | 1845 |
| H-index | 20 | 20 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 101 | 101 |
| Total Cites to Single+First Authored Papers | 329 | 351 |
| Number of Single+First+Last Authored Papers | 276 | 276 |
| Total Cites to Single+First+Last Authored Papers | 687 | 721 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1384 | 1452 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
6.67%
|
|
Younes, Anas
Memorial Sloan-Kettering Cancer Center,
United States
2024 Rank: 17140
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 379 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17140 | 18354 |
| Total Cites | 1872 | 2035 |
| H-index | 21 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 31 | 31 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 99 | 99 |
| Total Cites to Single+First Authored Papers | 410 | 444 |
| Number of Single+First+Last Authored Papers | 274 | 274 |
| Total Cites to Single+First+Last Authored Papers | 838 | 897 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1415 | 1508 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.35 |
| Self-Citation Percentage |
8.01%
|
|
Younes, Anas
Memorial Sloan-Kettering Cancer Center,
United States
2023 Rank: 15710
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 574 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15710 | 15994 |
| Total Cites | 1985 | 2163 |
| H-index | 21 | 22 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 31 | 31 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 98 | 98 |
| Total Cites to Single+First Authored Papers | 460 | 500 |
| Number of Single+First+Last Authored Papers | 273 | 273 |
| Total Cites to Single+First+Last Authored Papers | 898 | 957 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1482 | 1573 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.38 |
| Self-Citation Percentage |
8.23%
|
|
Younes, Anas
Memorial Sloan-Kettering Cancer Center,
United States
2022 Rank: 13260
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 500 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13260 | 13633 |
| Total Cites | 2019 | 2222 |
| H-index | 21 | 22 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 30 | 30 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 96 | 96 |
| Total Cites to Single+First Authored Papers | 482 | 537 |
| Number of Single+First+Last Authored Papers | 270 | 270 |
| Total Cites to Single+First+Last Authored Papers | 922 | 998 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1507 | 1615 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.38 |
| Self-Citation Percentage |
9.14%
|
|
Younes, Anas
Memorial Sloan-Kettering Cancer Center,
United States
2021 Rank: 11744
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 429 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11744 | 12159 |
| Total Cites | 3189 | 3558 |
| H-index | 26 | 27 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 30 | 30 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 96 | 96 |
| Total Cites to Single+First Authored Papers | 823 | 923 |
| Number of Single+First+Last Authored Papers | 266 | 266 |
| Total Cites to Single+First+Last Authored Papers | 1537 | 1677 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2302 | 2468 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.44 |
| Self-Citation Percentage |
10.37%
|
|
Younes, Anas
Memorial Sloan-Kettering Cancer Center,
2020 Rank: 8995
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 330 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8995 | 9504 |
| Total Cites | 2469 | 2739 |
| H-index | 23 | 24 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 95 | 95 |
| Total Cites to Single+First Authored Papers | 686 | 745 |
| Number of Single+First+Last Authored Papers | 259 | 259 |
| Total Cites to Single+First+Last Authored Papers | 1267 | 1350 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1729 | 1881 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.46 |
| Self-Citation Percentage |
9.86%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.